FDA Approved: ANTHIM — Supplemental Application (Elusys Therapeutics, Inc.)

View source ↗

Summary

FDA approved a supplemental application for ANTHIM (obiltoxaximab) from Elusys Therapeutics, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax
• Inhalational Anthrax

Drugs mentioned

• ANTHIM (obiltoxaximab)

Snippet

SUPPL AP for ANTHIM (OBILTOXAXIMAB)